Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SENOMAC-ULTRA: A Prospective Randomised Trial on the Omission of Axillary Lymph Node Dissection in Ultrasound-detectable Axillary Metastases in Primary Breast Cancer Treated by Upfront Surgery

NCT06869629 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06869629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06869629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SENOMAC-ULTRA: A Prospective Randomised Trial on the Omission of Axillary Lymph Node Dissection in Ultrasound-detectable Axillary Metastases in Primary Breast Cancer Treated by Upfront Surgery
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Recruiting
Start date
May 13, 2026
Completion date
December 31, 2041
Enrollment
1,380 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast carcinoma, breast surgery